Latest filing published 14 Jan 2021 for ENDRA Life Sciences Inc., €5,443.
Filing timeline
BuySaleInsider track record
Renaud Bertrand Maloberti: trading record in brief
This profile gathers the share dealings of Renaud Bertrand Maloberti in ENDRA Life Sciences Inc. Between 9 April 2020 and 13 January 2021, the trades on record add up to 8 filings.
The open-market record consists of 7 sales worth €61k, with no purchase. The rest of the record consists of 1 share grant. Since January 2021: no purchases and 4 sales on the market.
The newest entry dates from 14 January 2021: an open-market sale of €5,443, in ENDRA Life Sciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Renaud Bertrand Maloberti
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,304 shares@ US$1.058.9% of flowCommon StockSEC:0001209191-21-003597:0
- 13,696 shares@ US$1.1020.2% of flowCommon StockSEC:0001209191-21-003597:1
- 8,731 shares@ US$0.9411.0% of flowCommon StockSEC:0001209191-21-002828:0
- 11,269 shares@ US$0.9414.1% of flowCommon StockSEC:0001209191-21-002371:0
- 25,000 shares@ US$0.7353.5% of flowCommon StockSEC:0001209191-20-064584:0
- 10,000 shares@ US$0.8124.6% of flowCommon StockSEC:0001209191-20-058450:0
- 10,000 shares@ US$0.7221.9% of flowCommon StockSEC:0001209191-20-053429:0
- 86,580 shares0Common StockSEC:0001209191-20-024214:0
8 of 8 declarations
